drugset / Trial / NCT03596970
Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.
RandomizedParallel-groupOpen-labelTreatment
Summary
A 24-month multi-center, open-label, randomized, controlled study to evaluate the evolution of renal function in maintenance liver transplant recipients receiving everolimus plus reduced TAC or everolimus plus mycophenolate mofetil (MMF)
Timeline
- Start
- 2015-09
- Primary completion
- 2020-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Everolimus | Small molecule | — | — |
| Comparator | Everolimus with reduced TAC | Unknown | — | — |
| Subject | Mycophenolate Mofetil | Small molecule | — | — |
Indications
No indication recorded.